Today: 21 May 2026
Browse Category

NASDAQ:RKLB 13 February 2026 - 21 May 2026

Rocket Lab Shares Slide Premarket On $3 Billion Sale Plan During SpaceX IPO Week

Rocket Lab Shares Slide Premarket On $3 Billion Sale Plan During SpaceX IPO Week

Rocket Lab filed to sell up to $3 billion in common stock, sending shares down to $126.75 in premarket trading from Wednesday’s $134.28 close. The move comes as SpaceX filed for a public IPO, raising valuation pressure across the sector. Rocket Lab’s year-to-date gain stood near 92% before the late-Wednesday announcement. The company reported $200.3 million in Q1 revenue and a $2.2 billion backlog.
Redwire Stock Just Jumped 27% — The $498 Million Number Traders Can’t Ignore

Redwire Stock Just Jumped 27% — The $498 Million Number Traders Can’t Ignore

Redwire shares jumped 27% over five sessions, closing Friday at $14.06 after a surge in orders and defense-drone interest, despite a $76.5 million quarterly loss. The company reported first-quarter revenue of $97 million and a record $498.1 million backlog. Redwire will showcase new uncrewed aircraft systems at SOF Week in Tampa starting Monday. A new share-sale program could raise up to $350 million.
Tema NASA ETF Watch as SpaceX IPO Talk Grows

Tema NASA ETF Watch as SpaceX IPO Talk Grows

Tema Space Innovators ETF fell 3.9% to $34.51 Friday but gained 7.5% for the week. The fund holds $707.3 million in assets, with Rocket Lab and SpaceX SPV among top positions. Reuters reported SpaceX may file for a Nasdaq IPO as soon as next week, targeting a $1.75 trillion valuation. SpaceX shareholders approved a 5-for-1 stock split, effective the week of May 18.
Redwire Stock Jumps Again as $498 Million Backlog Puts Defense Growth Back in Play

Redwire Stock Jumps Again as $498 Million Backlog Puts Defense Growth Back in Play

Redwire shares jumped nearly 14% to $13.04 Thursday after reporting first-quarter revenue up 57.9% to $97 million and reaffirming its 2026 sales outlook. The company ended March with a $498.1 million backlog but posted a $76.5 million net loss. Redwire also launched a $350 million at-the-market share program, raising dilution concerns.
RKLB Stock Pulls Back After Breakout as Neutron Demand Starts to Set the Price

RKLB Stock Pulls Back After Breakout as Neutron Demand Starts to Set the Price

Rocket Lab shares fell 2.4% to $114.58 Tuesday after hitting an all-time high of $123.94 Monday, following a 40% rally last week. The company reported Q1 revenue of $200.3 million, a $2.2 billion backlog, and more launch contracts booked in three months than in all of 2025. Investors cited both profit-taking and continued bullish sentiment on Neutron and defense demand.
Rocket Lab Stock Jumps 34%: The $2.2 Billion Backlog Wall Street Wanted to See

Rocket Lab Stock Jumps 34%: The $2.2 Billion Backlog Wall Street Wanted to See

Rocket Lab shares jumped 34.3% to a record $105.55 after reporting first-quarter revenue of $200.3 million, up 63.5% year-over-year, and a $2.2 billion launch backlog. The company signed 31 Electron and HASTE launch contracts and five Neutron launches, pushing its manifest above 70 missions. Rocket Lab also announced a $30 million hypersonic test contract with Anduril and a new partnership with Raytheon on missile defense.
Intuitive Machines Stock Jumps 20% Ahead of Earnings: Why LUNR Is Back in the Space-Race Trade

Intuitive Machines Stock Jumps 20% Ahead of Earnings: Why LUNR Is Back in the Space-Race Trade

Intuitive Machines shares surged 20.2% to $28.97 on Friday, with trading volume and call options activity spiking ahead of its May 14 earnings report. Options traders bought 16,864 call contracts, double the usual level. The rally followed gains in other space stocks, including Rocket Lab, which jumped 34.2% after strong results. Intuitive Machines last reported a $59.7 million quarterly loss on $44.8 million revenue.
Rocket Lab Stock Pops After Record $200 Million Quarter. The Bigger Story Is Neutron

Rocket Lab Stock Pops After Record $200 Million Quarter. The Bigger Story Is Neutron

Rocket Lab shares jumped 6.6% in premarket trading after reporting record Q1 revenue of $200.3 million and announcing its largest-ever launch contract, covering five Neutron and three Electron missions. The company’s backlog rose above $2.2 billion. Rocket Lab also won a $30 million contract from Anduril for hypersonic test launches and was selected with Raytheon for a U.S. Space Force program. Net loss narrowed to $45 million.
Rocket Lab Stock Slips as SpaceX IPO Hype Meets a Hard Earnings Test

Rocket Lab Stock Slips as SpaceX IPO Hype Meets a Hard Earnings Test

Rocket Lab shares fell 2.3% to $77.83 Monday, extending recent volatility as investors await first-quarter results due May 7. A technical note flagged weak near-term sentiment despite strong annual revenue growth and a $1.85 billion backlog. SpaceX’s planned IPO has increased scrutiny of space-sector valuations. Rocket Lab completed its second dedicated launch for JAXA on April 23.
Why Rocket Lab Stock Is Rising Again as Analysts Lift Targets and Golden Dome Spending Comes Into Focus

Why Rocket Lab Stock Is Rising Again as Analysts Lift Targets and Golden Dome Spending Comes Into Focus

Rocket Lab shares rose 2% to $91.12 Tuesday after analysts raised price targets and the Pentagon detailed new space defense spending in its 2027 budget request. The company closed its $155 million Mynaric acquisition last week and reported a $190 million Pentagon launch contract in March, bringing its backlog above $2 billion. Rocket Lab now expects to launch its Neutron rocket in late 2026 after a test setback.
Rocket Lab Stock Jumps as Mynaric Deal, Gauss Thruster Fuel Fresh Bullish Calls

Rocket Lab Stock Jumps as Mynaric Deal, Gauss Thruster Fuel Fresh Bullish Calls

Rocket Lab shares rose 9% Thursday after launching a new electric satellite thruster and closing its $155.3 million acquisition of Mynaric. Shares traded at $80.39 by 11:30 a.m. EDT. The company reported $602 million in 2025 revenue and a $1.85 billion backlog. Rocket Lab delayed its Neutron rocket to late 2026 after a tank test failure.
SpaceX IPO Buzz Puts Rocket Lab, Planet Labs and 3 Other Space Stocks in Focus

SpaceX IPO Buzz Puts Rocket Lab, Planet Labs and 3 Other Space Stocks in Focus

Planet Labs jumped 16.9% in premarket trading Monday, leading gains among U.S.-listed space stocks as investors sought public alternatives to SpaceX ahead of its expected IPO. Rocket Lab rose 3.3%, Viasat 18.7%, BlackSky 11.5%, and Redwire 7.2%. SpaceX’s confidential IPO filing and talks with Saudi Arabia’s Public Investment Fund have intensified focus on sector peers.
Rocket Lab Stock Jumps as Germany Clears Mynaric Buyout, Putting Europe Push in Reach

Rocket Lab Stock Jumps as Germany Clears Mynaric Buyout, Putting Europe Push in Reach

Germany approved Rocket Lab’s acquisition of Mynaric, clearing the way for the $75 million deal to close in April. Rocket Lab shares rose 6.7% to $61.21 in early U.S. trading Tuesday. The purchase gives Rocket Lab its first European base in Munich and direct control over a key laser-communications supplier. Mynaric will remain headquartered in Munich after the deal closes.
AST SpaceMobile Sets April 10 BlueBird 7 Target as Rocket Lab Notches ESA Launch After SpaceX IPO Buzz

AST SpaceMobile Sets April 10 BlueBird 7 Target as Rocket Lab Notches ESA Launch After SpaceX IPO Buzz

Blue Origin’s New Glenn-3 is now targeting April 10 to launch AST SpaceMobile’s BlueBird 7 satellite, later than previous timelines. Rocket Lab completed its first dedicated launch for the European Space Agency on March 28, sending two Celeste satellites into orbit. AST reported $70.9 million in 2025 revenue and over $3.9 billion in cash and liquidity at year-end. Rocket Lab holds a $1.85 billion backlog.
Rocket Lab’s $190 Million Hypersonic Contract Swells Backlog as Stock-Sale Plan Keeps Shares in Focus. (Rocket Lab Corporation)

Rocket Lab’s $190 Million Hypersonic Contract Swells Backlog as Stock-Sale Plan Keeps Shares in Focus. (Rocket Lab Corporation)

Rocket Lab shares fell 6.5% premarket Monday after securing a record $190 million U.S. military hypersonic-test contract and announcing a plan to sell up to $1 billion in stock. The company’s backlog rose above $2 billion, boosted by defense orders and a new 20-mission HASTE deal. Rocket Lab launched its 84th Electron flight Friday for Synspective. First-quarter revenue is projected at $185 million to $200 million.
Rocket Lab Stock Slides After $1 Billion Share-Sale Plan Cuts Into Neutron-Fueled Rally

Rocket Lab Stock Slides After $1 Billion Share-Sale Plan Cuts Into Neutron-Fueled Rally

Rocket Lab shares dropped 8.8% to $71.65 by midday Wednesday after the company filed to sell up to $1 billion in common stock through an at-the-market offering. The move follows a 10.2% rally Tuesday on Neutron rocket progress and defense contract gains. Rocket Lab reported $180 million in Q4 revenue and ended 2025 with $828.7 million in cash. The company warned the share sale could dilute existing shareholders.
Rocket Lab stock price swings as $1 billion share-sale filing dents rally

Rocket Lab stock price swings as $1 billion share-sale filing dents rally

Rocket Lab shares fell more than 5% after hours Tuesday following a filing to sell up to $1 billion in stock through an at-the-market program and forward sale agreements. The company ended 2025 with $1.1 billion in cash and is ending a prior $750 million stock-sale program. Rocket Lab reported record 2025 revenue but delayed the first Neutron rocket launch to late 2026 after a tank test failure.
Rocket Lab stock price drops 5% as space stocks slide; hypersonic test and Feb. 26 earnings loom

Rocket Lab stock price drops 5% as space stocks slide; hypersonic test and Feb. 26 earnings loom

Rocket Lab shares closed down 5.2% at $66.01 Thursday, extending an 8% three-day slide as space stocks fell after AST SpaceMobile’s $1 billion debt deal. The company flagged a late-February hypersonic test for the U.S. Defense Innovation Unit and will report results Feb. 26, with investors awaiting updates on its Neutron rocket schedule.
1 2 3 11

Stock Market Today

  • Trump Invests Up to $2.4M in Pharma Stocks Linked to US Drug Price Deals
    May 21, 2026, 9:19 AM EDT. In Q1 2026, US President Donald Trump invested between $925,000 and $2.56 million in nine pharmaceutical companies involved in drug price agreements under his administration's Most Favored Nation (MFN) policy. This strategy aims to align US drug prices with the lowest international rates. Key investments included Eli Lilly ($680,000), Johnson & Johnson ($480,000), and Bristol Myers Squibb ($465,000). These companies signed deals to lower medicine costs after Trump's 2025 letter demanding price cuts. Legal experts warn that his stock purchases in firms impacted by his policies could erode public trust in government decisions. Transactions were managed by external advisors, highlighting ongoing concerns about potential conflicts of interest.

Latest articles

Redwire Stock Faces a Hard Test After Drone Wins and a Sponsor Exit

Redwire Stock Faces a Hard Test After Drone Wins and a Sponsor Exit

21 May 2026
NEW YORK, May 21, 2026, 08:36 EDT Redwire Corporation shares eased in premarket trading on Thursday, giving back part of a sharp prior-session gain as investors weighed two new unmanned-aircraft orders against a sponsor sell-down disclosed in securities filings. The stock closed at $14.77 on Wednesday, up 6.18%, and was quoted at $14.36 in premarket trade. Its market value was listed at about $2.94 billion. U.S. equity markets are on a normal schedule Thursday, ahead of the Memorial Day closure on Monday, May 25. (Google) The news matters now because Redwire is trying to turn demand for space and defense
POET Eyes $400 Million Raise as Traders Focus on Key Risk

POET Eyes $400 Million Raise as Traders Focus on Key Risk

21 May 2026
POET Technologies shares fell in premarket trading Thursday after a $400 million direct offering of 19.05 million shares and warrants. The stock closed Wednesday at $14.78, up 13.1%, but slipped to $14.38 before the open. Proceeds will fund a major manufacturing expansion. The sole buyer was MMCAP International Inc. SPC.
MARA Stock Just Jumped — Now Its $1.5 Billion AI Power Bet Faces a Test

MARA Stock Just Jumped — Now Its $1.5 Billion AI Power Bet Faces a Test

21 May 2026
MARA Holdings shares slipped to $13.10 in pre-market trading Thursday after a 5.7% jump, as insider filings showed CEO Fred Thiel and CFO Salman Khan sold shares at $12 each under pre-arranged plans. The moves follow MARA’s $1.5 billion deal to acquire Long Ridge Energy & Power, adding a 505-megawatt Ohio gas plant and land for AI-focused data centers. The transaction awaits regulatory approval and is expected to close in late 2026.
Go toTop